These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 23761583
1. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study. Mukhtar TK, Yeates DR, Goldacre MJ. J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583 [Abstract] [Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, Evans A, Blyuss O, Johns L, Ellis I, Sasieni P, Wale C, Myles J, Moss S. Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [Abstract] [Full Text] [Related]
3. Breast cancer mortality in organised mammography screening in Denmark: comparative study. Jørgensen KJ, Zahl PH, Gøtzsche PC. BMJ; 2010 Mar 23; 340():c1241. PubMed ID: 20332505 [Abstract] [Full Text] [Related]
4. Screening for breast cancer in England: past and future. Advisory Committee on Breast Cancer Screening. J Med Screen; 2006 Mar 23; 13(2):59-61. PubMed ID: 16792825 [Abstract] [Full Text] [Related]
5. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Johns LE, Coleman DA, Swerdlow AJ, Moss SM. Br J Cancer; 2017 Jan 17; 116(2):246-252. PubMed ID: 27931047 [Abstract] [Full Text] [Related]
6. Assessment of Breast Cancer Mortality Trends Associated With Mammographic Screening and Adjuvant Therapy From 1986 to 2013 in the State of Victoria, Australia. Burton R, Stevenson C. JAMA Netw Open; 2020 Jun 01; 3(6):e208249. PubMed ID: 32573707 [Abstract] [Full Text] [Related]
7. Radiation risk of breast screening in England with digital mammography. Warren LM, Dance DR, Young KC. Br J Radiol; 2016 Nov 01; 89(1067):20150897. PubMed ID: 27585843 [Abstract] [Full Text] [Related]
8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2007 Nov 01; 7(1):1-32. PubMed ID: 23074501 [Abstract] [Full Text] [Related]
9. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, Warren R, Watson E, Whynes D, Allgood P, Caunt J. Health Technol Assess; 2013 Mar 01; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [Abstract] [Full Text] [Related]
10. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up. Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, Looman CWN, van Luijt PA, Fracheboud J, den Heeten GJ, Broeders MJM, de Koning HJ. Int J Cancer; 2017 Aug 15; 141(4):671-677. PubMed ID: 28457023 [Abstract] [Full Text] [Related]
11. Changes in breast cancer risk distribution among Vermont women using screening mammography. Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. J Natl Cancer Inst; 2014 Aug 15; 106(8):. PubMed ID: 24957223 [Abstract] [Full Text] [Related]
12. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer Screening. Lancet; 2003 Apr 26; 361(9367):1411-7. PubMed ID: 12727393 [Abstract] [Full Text] [Related]
14. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011. Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Br J Cancer; 2017 Mar 14; 116(6):828-839. PubMed ID: 28183141 [Abstract] [Full Text] [Related]
15. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfússon B. BMJ; 1988 Oct 15; 297(6654):943-8. PubMed ID: 3142562 [Abstract] [Full Text] [Related]
16. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women. Zakaria D, Shaw A. Cancer Causes Control; 2019 Feb 15; 30(2):137-147. PubMed ID: 30637599 [Abstract] [Full Text] [Related]
17. Incidence-Based Breast Cancer Mortality Trends in Estonia Before and After the Introduction of Organized Mammography Screening: A Register-Based Study. Baburin A, Veerus P, Lang K, Innos K. Cancer Control; 2024 Feb 15; 31():10732748241266491. PubMed ID: 39092882 [Abstract] [Full Text] [Related]
18. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Webb ML, Cady B, Michaelson JS, Bush DM, Calvillo KZ, Kopans DB, Smith BL. Cancer; 2014 Sep 15; 120(18):2839-46. PubMed ID: 24018987 [Abstract] [Full Text] [Related]
19. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women. Hendrick RE. Radiology; 2018 May 15; 287(2):391-397. PubMed ID: 29267146 [Abstract] [Full Text] [Related]
20. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Lancet; 2003 Apr 26; 361(9367):1405-10. PubMed ID: 12727392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]